Profile
AmacaThera is a venture-backed clinical stage biotechnology company supported by institutional investors including; Lumira Ventures, BDC Capital’s Women in Technology Venture Fund, Inveready, StandUp Ventures, MaRS IAF, and Changrong Capital. AmacaThera is specializing in the development of advanced sustained release hydrogel formulations to solve key therapeutic delivery challenges with both off-patent and proprietary payloads. AmacaThera is focused on developing an internal pipeline of pain management and oncology assets; and partnering to solve key delivery challenges with advanced proprietary therapeutic modalities.
Website
Contact
-
Mike Cooke, Co-Founder and Chief Executive OfficerTel: +1 647-518-6776Email: mikejcooke@amacathera.ca
-
-
-
-
-
Event details
Date: January 13 - 15, 2025
Event contact
Patricia Cosgrove
Area Director
USA: Life Sciences
Tel: +1 647-293-6306
Email: patricia.cosgrove@ontario.ca
Participants
21 in total
-
20/20 OptimEyes Technologies has developed a mucoadhesive drug delivery platform technology that allows for… -
AmacaThera is a venture-backed clinical stage biotechnology company supported by institutional investors…
-
Custom Biologics is a regulatory compliant, large molecule bioanalytical… -
Esphera SynBio is developing next-generation cancer and immunoregulatory treatments through its innovative… -
Eurofins CDMO Alphora Inc. provides integrated solutions for small molecules, drug product,… -
For over two decades, Toronto area-based GL CHEMTEC has been dedicated to delivering innovative… -
HDAX Therapeutics is a biotechnology company pioneering a novel approach to targeting… -
ImmunoBiochem is an innovative, pharma-partnered biotech on a mission to develop novel bioconjugate therapeutics… -
Inteligex Inc. is a regenerative medicine company focused on improving clinical outcomes for patients with… -
Iseehear Inc. is a leading provider of comprehensive IT solutions for the biomedical research… -
Mannin Research Inc. is a Canadian private biotechnology company, headquartered in Toronto, Ontario. It is… -
Mediphage, a Toronto-based biotechnology company, has developed a proprietary and scalable manufacturing process… -
Plasmid DNA is starting material for cell and gene, RNA and DNA therapies… -
Nucro-Technics is a full-service Contract Support Organization that specializes in the conduct of both… -
Oxford Cancer Analytics (OXcan) is creating a paradigm shift in early disease detection, monitoring… -
Pattern Pharma’s patent-protected immunotherapeutic, PPI-100, mobilizes innate immunity by targeting… -
ProteinQure has built the best computational platform for designing peptides for extra-cellular targets. Its lead… -
PurMinds NeuroPharma is a neuro-medicine development company pursuing breakthrough solutions for the treatment of… -
QurCan Therapeutics is developing tissue and cell-targeted genetic medicine using its proprietary hybrid polymer-… -
Spiderwort is a tissue engineering company that develops cellulose-based scaffolds for use in regenerative… -
TheraVac Biologics is developing novel vaccines and immunotherapies for aging-related diseases associated with…